Zobrazeno 1 - 1
of 1
pro vyhledávání: '"ConPlas-19 Study Group"'
Autor:
Avendaño-Solá, Cristina, Ramos-Martínez, Antonio, Muñez-Rubio, Elena, Ruiz-Antorán, Belen, Malo de Molina, Rosa, Torres, Ferran, Fernández-Cruz, Ana, Calderón-Parra, Jorge, Payares-Herrera, Concepcion, Díaz de Santiago, Alberto, Romera-Martínez, Irene, Pintos, Ilduara, Lora-Tamayo, Jaime, Mancheño-Losa, Mikel, Paciello, Maria L, Martínez-González, A L, Vidán-Estévez, Julia, Nuñez-Orantos, Maria J, Saez-Serrano, Maria Isabel, Porras-Leal, Maria L, Jarilla-Fernández, Maria C, Villares, Paula, de Oteyza, Jaime Pérez, Ramos-Garrido, Ascension, Blanco, Lydia, Madrigal-Sánchez, Maria E, Rubio-Batllés, Martin, Velasco-Iglesias, Ana, Paño-Pardo, José R, Moreno-Chulilla, J A, Muñiz-Díaz, Eduardo, Casas Flecha, Inmaculada, Perez-Olmeda, Mayte, García-Pérez, Javier, Alcamí, José, Bueno, Jose L, Duarte, Rafael F, ConPlas-19 Study Group
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
J Clin Invest
Instituto de Salud Carlos III (ISCIII)
J Clin Invest
Background: Passive immunotherapy with convalescent plasma (CP) is a potential treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. Methods: We conducted a randomized, open-label, controlled clinical trial at 27 hospitals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bdb98cd96e8984b092b4a7fe340dc64
https://hdl.handle.net/20.500.12105/14730
https://hdl.handle.net/20.500.12105/14730
